Download presentation
Presentation is loading. Please wait.
Published byGerhardt Schneider Modified over 5 years ago
1
Interprofessional Approach to Managing Adverse Events of PI3K Inhibitors
3
Approved PI3K Inhibitors
4
PI3K Isoforms and Inhibitors
5
Common AEs With PI3K Inhibitors
6
Possible Reasons for Drug-Specific AEs
7
Black Box Warnings With PI3K Inhibitors
8
Overview of Healthcare Team Model
9
Case 1
10
Case 1: Educating the Patient
11
Case 1 (cont)
12
Case 1: Notes on Diarrhea
13
Case 1: Management of Diarrhea
14
Case 1: Pearls on Team Management of Diarrhea
15
Case 1: Wrap-Up and Discussion
16
Case 2
17
Case 2: Copanlisib vs Other PI3K Inhibitors
18
Case 2: Notes on Hyperglycemia
19
Case 2: Notes on Hyperglycemia (cont)
20
Case 2: Team-Based Monitoring and Diagnosis
21
Case 2: Management of Hyperglycemia
22
Case 2: Pearls on Managing Hyperglycemia
23
Case 2: Wrap-Up and Discussion
24
Case 3
25
Case 3: Risk of Infection
26
Case 3: Drug-Drug Interactions
27
Case 3 (cont)
28
Case 3: Notes on Pneumonia and Pneumonitis
29
Case 3: Management of Infectious Pneumonia
30
Pneumonitis vs Viral Infection
31
Sum-Up: General Principles of Management
32
Sum-Up: Pearls for Team-Based Care
33
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.